|Continuation of Combo Treatment
Aug 8, 2008
Dear Dr. McGovern,
I am a 33 year old Asian American male with chronic HBV diagnosed two years ago. my HBV DNA levels have been undetectable since Jan 2008 when I began drug combination of Baraclude and Viread. Prior to, monotherapy of Baraclude, and combination of Baraclude and Hepsera was able to reduce DNA levels but unable to reduce below detectable range.
During my last visit, my doctor suggested that we may switch back to monotherapy with Viread. Amongst the reasons is long term financial consideration.
What is your opinion at this point?
Thank you very much!
Response from Dr. McGovern
If I understand you correctly, you did not have viral suppression on Baraclude monotherapy, but then did achieve viral suppression when Hepasera was added.
The financial considerations are certainly something to think about. Viread is felt to be more potent than Hepsera in suppressing HBV. I suspect that switching to Viread monotherapy would be successful. However, close follow-up is very important. I would follow HBV DNA levels every three months for the next six months at least to be certain that you maintain a non detectable viral load.
Best of luck!
ACUTE hepatitis C
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.